Evidence map›Paper›PMID 41210772›Full record

ReviewACS omega2025

Similarity-Based Profiling of Hydrazone-Containing Scaffolds Active Against

Rita Yanka Pereira da Silva, Jheynne Laina Alves de Lima, Samara Beatriz de Abreu Pinto, Lamark Carlos I, Alessandro Kappel Jordão, Euzébio Guimarães Barbosa

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rita Yanka Pereira da SilvaDepartment of PharmacyCCS, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte 59012-570, Brazil.
Jheynne Laina Alves de LimaDepartment of PharmacyCCS, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte 59012-570, Brazil.ORCID https://orcid.org/0009-0007-4939-1806
Samara Beatriz de Abreu PintoDepartment of PharmacyCCS, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte 59012-570, Brazil.
Lamark Carlos IDepartment of PharmacyCCS, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte 59012-570, Brazil.
Alessandro Kappel JordãoDepartment of PharmacyCCS, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte 59012-570, Brazil.
Euzébio Guimarães BarbosaDepartment of PharmacyCCS, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte 59012-570, Brazil.ORCID https://orcid.org/0000-0002-7685-9618

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review explores the potential of hydrazone-containing scaffolds as anti-leishmanial agents with a particular focus on their activity against intracellular

Identifiers

PMID41210772
PMCPMC12593058

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.